CBD hearing reinforces the need for the FDA to move quickly

According to The Washington Post, the U.S. Food and Drug Administration (FDA) launched the agency’s first hearing on cannabidiol (CBD) products on May 31 with a laundry of list of questions on the ingredient, which can be derived from marijuana or hemp.

Daily News | Article